Biomillenia is a company focused on restoring a robust and resilient microbiota, they have recently launched a microbiome culture collection service. By applying its proprietary microbiome-on-a-chip technology platform to identify previously uncultured bacteria, Biomillenia is able to build a highly diverse culture collection from single cells from any natural sample (animals, plants, humans and or from soil and sea water). 

Biomillenia’s microbiome-on-a-chip technology contains more than 100 million parallel picoliter-size droplets, enabling a much higher diversity of live bacterial species that can grow to clonal populations than standard microbiology methods. In addition to unbiased culture collection services, partners have the option to include phenotypic selection, effectively screening for novel bacterial strains with desired traits. Biomillenia is able to screen up to 100 million microbes in parallel in a two milliliter culture volume in 7-10 days, whereas traditional culture methods would take approximately 3 years in 10,000 liter reaction volume.

“The microbiome is a vast natural pool of mostly undiscovered microbes that can be leveraged across several industries, including agriculture, animal health, food and consumer health. We are supporting companies in these sectors by providing access to our microbial culture collection services and state of the art microbe isolation and sequencing technologies,” said Dirk Loeffert, Ph.D., CEO of Biomillenia. “We have already seen several new partners sign up to build culture collections in healthcare and consumer health. This is a very encouraging start to our new service offering.”

If you are interested in discussing Biomillenia's microbiome culture collection service, please contact d.loeffert@biomillenia.com.